マドリードで最高のCT検査医師 - トップ16名の医師

Experience

• -Head of the Department of Functional Neurosurgery and Radiosurgery at Ruber International Hospital since 2005 .
• - Neurosurgeon in the Radiosurgery Department of Ruber International Hospital since 1993 .
• -Work experience at Puerta de Hierro Clinic, Madrid (1985–1989) .

Scientific and teaching activities

• -180 publications in national and international medical journals.
• 60 articles in leading international journals with high impact factor.
• - Participation in 230 scientific conferences as a speaker, including 100 invited presentations at international symposia.
• -Author : 3 published books and 22 chapters in scientific papers.
• - Honorary Professor of the Faculty of Medicine of the Autonomous University of Madrid .

Internships in international centers

• - La Timone Hospital, Marseille (France) – 2000, 2010, 2015.
• -Karolinska Hospital, Stockholm (Sweden) – 1993, 1996.
• - Birmingham Hospital, UK – 1987

Membership in scientific societies

• - Member of the International Society of Stereotactic Radiosurgery (ISRS) , is a member of the Executive Council and the Educational Committee .
• - Member of the Congress of Neurological Surgeons of the United States and the American Association of Neurological Surgeons .
• -Member of the Royal Academy of Medicine of Asturias, Spain .

Languages of practice

• -Spanish
• -English
• -French

Pathologies

-Benign brain tumors: meningiomas and neuromas:

-Cerebral vascular malformations:

-Obsessive-compulsive disorder treatment operations:

-Operations to combat nervous anorexia:

Publications

2023 | Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma in patients ≥ 65 years: a multi-institutional retrospective study Acta Neurochirurgica 165: 211–220,

2022 | Stereotactic radiosurgery for Kues grade IV vestibular schwannoma in young patients: a multi-institutional study Journal of Neuro-Oncology 160: 201–208.

2022 | Stereotactic radiosurgery versus active surveillance for asymptomatic, parafalcine, and parasagittal meningiomas: a matched cohort analysis from the IMPASSE Neurosurgery 90:750–757

2022| Active surveillance versus stereotactic radiosurgery for the treatment of patients with incident frontobasal meningioma - A subanalysis of the IMPASSE Cancers (Basel) trial. Mar 3;14(5):1300.

2022| Gamma Knife Outcomes and Recommendations and Complications: Patai fond Kuala Lumpur

2022| Radiosurgery for Mental Disorders LGKA Marsella

2022| The Role of SRS in Anorexia Nervosa ISRS Milan

2022| Expanding the indications for gamma knife radiosurgery Neuroonc and Rs Symp Malasia

2022 | Pituitary Adenoma: Conservative in Surgical Abortion Simp CUF Lisbo

Awards and certificates

2019|National Medical Prize XXI in the field of neurosurgery.

2018 | Editorial Board Member, American Journal of Psychiatry and Neurology

2015 | Factory Award torn away from the International Society of Stereotactic and Radiosurgery

2012 | Correspondent of the Real Medical Academy of Asturias.

A traumatologist and orthopedic surgeon based in Madrid with nearly 30 years of experience. Throughout his extensive career, he has specialized in the diagnosis and treatment of knee joint pathologies, shoulder joint conditions, sports injuries, ankle disorders, knee joint prosthetics, robotic surgery, and knee trauma.

Graduated from the Faculty of Medicine and Surgery at the University of Navarra, specializing in Orthopedic Surgery and Traumatology at the same institution. Additionally, he earned a doctorate in Medicine and Surgery. Based on the MIR rankings, he was recognized as the resident with the best resume in Spain across all specialties.

Later, he pursued advanced training in shoulder surgery in California and completed internships at ten hospitals in the UK and the USA, including the Mayo Clinic in Rochester, as well as the universities of Miami, Oxford, and Cambridge.

Throughout his professional career, he has served as a medical consultant for various clinics and centers, as well as for professional teams such as the Cleveland Cavaliers (NBA), Cleveland Browns (NFL), and Cleveland Indians (baseball). Additionally, he has worked as a trauma consultant for several football teams, including Atlético Madrid, Getafe, and Real Zaragoza, and has collaborated with Spanish federations for gymnastics, judo, and karate.

**Experience**  

- Director of Rights, Partnerships, and Colors at Olympia Quironsalud.  

- Orthopedic Surgery and Traumatology residency through MIR (rank 80) at the University Clinic of Navarra, Pamplona.  

- Clinical Fellow at the Orthopedic and Traumatology Department, University Clinic of Navarra, Pamplona.  

- Clinical Fellow at Cleveland Clinic Foundation, Cleveland.  

- Assistant Traumatologist at the Dexeus University Institute (ICATME), Barcelona.  

- Assistant Traumatologist at the Galicia Institute of Orthopedic Surgery and Sports Medicine (IGACOTDE), Hospital Santa Teresa, La Coruña.  

- Specialist in Traumatology at CEMTRO Clinic, Madrid.  

- Head of the Knee Department at FREMAP Hospital, Majadahonda.

CLINICAL ROTATIONS ABROAD

- University of Miami. Jackson Memorial Hospital. Florida, USA. 5 months  

- Kleinert Institute of Hand Surgery. Louisville, Kentucky, USA. 1 month  

- John Radcliffe Hospital. Oxford, England. 3 weeks  

- Nuffield Orthopaedic Centre. Oxford, England. 3 weeks  

- Mayo Clinic. Rochester, Minnesota, USA. 3 weeks  

- O'Connor Hospital. San Jose, California, USA. 3 weeks  

- Wellington Hospital. London, England. 1 week  

- Princess Grace Hospital. London, England. 1 week  

- Addenbrooke's Hospital. Cambridge, England. 2 weeks  

- BUPA Cambridge Lee Hospital. Cambridge, England. 2 weeks  

- Cleveland Clinic Foundation. Cleveland, Ohio, USA. 2.5 years  

- 2002. WPOA Scholarship (Australia, New Zealand, Singapore). 4 weeks  

- Orthopaedic Institute of Southern California, USA. 4 weeks

Qualification

- Higher education in medicine and surgery. University of Navarra  

- Doctor of Medicine. University of Navarra  

- Specialist in orthopedic surgery and traumatology. University of Navarra Clinic, clinical fellowship in sports medicine. Cleveland Clinic Foundation  

- Clinical fellowship in foot and ankle surgery. Cleveland Clinic Foundation  

- Diploma in English from the School of Official Languages. A Coruña  

- ECFMG (Educational Commission for Foreign Medical Graduates)

Memberships

- AEA (Spanish Arthroscopy Association)  

- SEROD (Spanish Society for Knee Problems)  

- SECOT (Spanish Society of Orthopedic Surgery and Traumatology)  

- ESSKA (European Society of Sports Traumatology, Knee Surgery, and Arthroscopy) – International Society of Arthroscopy, Knee Surgery, and Orthopedic Sports (ISAKOS)  

- WARTHOG Orthopedic Society  

- MAGELLAN Orthopedic Society – SOMACOT (Madrid Society of Orthopedic Surgery and Traumatology)  

- Fellows Society of the Barry de la Maza Foundation

Other Achievements

- Former board member of SEROD (Spanish Society for Knee Problems)  

- Former board member of AEA (Spanish Arthroscopy Association)  

- Former editor of the journal *Cuadernos de Arthroscocoy* (AEA)  

- President of the AEA-SEROD Joint Congress 2015, Madrid  

- Member of the Arthroscopy Committee of ESSKA (European Society of Sports Traumatology, Knee Surgery, and Arthroscopy)  

- Member of the ESSKA Research Group on Knee Collateral Ligaments  

- Honorary member of the Argentine Arthroscopy Association  

- Patron of the Maria Pagés Foundation and Choreographic Center

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation systems, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation systems and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

Experience

On his return from London, he organized and directed the Arrhythmia Unit of the Cardiology Service of the University Hospital Nuestra Señora del Pino in Las Palmas until 2000.

He later became Deputy Director of the Arrhythmia Department and Director of the Electrophysiology Laboratory at the Jimenez Diaz Foundation in Madrid.

Professor of Cardiology at the Autonomous University and Director of the North American Society of Pacing and Electrophysiology (Heart Rhythm Society) Fellowship Program, positions he held for 6 years before moving to the Quironsalud University Hospital of Madrid in 2006.

Dr. Cabrera has been head of the cardiology department at the Quironsalud University Hospital of Madrid since its opening in 2006.

Since January 2013, he has also been Head of the Cardiology Department at the Ruber Juan Bravo Hospital Complex and, in 2022, Head of Service at the new Olimpia Center.

He is a professor at the European University of Madrid, where he heads the Department of Clinical and Fundamental Translational Cardiology.

Qualification

Doctorate in Medicine and Surgery from the Faculty of Medicine of the University of Granada. From 1994 to 1996 he completed postgraduate training as an interventional cardiologist in the Arrhythmia Unit (Cardiac Electrophysiology Laboratory) of the Jiménez Díaz Foundation in Madrid.

Senior Research Fellow. National Heart and Lung Institute. Royal Brompton. Paediatric Heart Morphology under the direction of Prof. Robert H. Anderson in London (UK) in 1997.

Research and Teaching

Member of the Spanish Society of Cardiology, SEC Arrhythmia Section, European Society of Cardiology, Arrhythmia Working Group, European Heart Rhythm Association, North American Society of Pacing and Electrophysiology.

He serves on numerous committees for the selection and monitoring of fellowships and research projects of various national and international cardiology and cardiac arrhythmia societies.

Reviewer of articles for publication in the most relevant journals in the specialty. Journal of the Spanish Society of Cardiology, Heart Rhythm, Journal of Cardiovascular Electrophysiology, PACE, Europace, Heart Circulation, Journal of the American College of Cardiology, Electrophysiology of Circulation, Journal of Interventional Cardiovascular Electrophysiology.

Member of the European Society of Cardiology

Member of the Arrhythmia Working Group

European Society of Cardiology

Member of the Arrhythmia Section of the Spanish Society of Cardiology.

Member of the European Society of Cardiology (FESC)

Member of the European Heart Rhythm Association.

Member of the Selection and Control Committee of the Spanish Society of Cardiology. Post-Residency Research Training Fellowships 2001-2002/2002-2003.

Evaluator and member of the selection committee for research, technological development and innovation projects of the Government of Extremadura. Ministry of Education, Science and Technology (2001-2004).

Member of the Spanish research group. Integrated Action Programme between Spain and the United Kingdom. Directorate General of Higher Education and Research (reference HB 1998-0030). Project title: Anatomical study of the cavities of the human heart and its application to clinical electrophysiology.

Member of the Spanish research group. Integrated Action Programme between Spain and Austria. Directorate General for Higher Education and Research (reference HU 1999-0002). Project title: Electromorphological analysis of the terminal crest and posterior pectineus muscle. Its importance as a morphological substrate in different types of supraventricular tachycardias.

Participation in the clinical commission and protocol of the study AZIMILIDE versus SOTALOL on programmed cardioversion in patients with atrial fibrillation. 2001-2003.

Dr. Javier Albiñana Silveti is a specialist in orthopedic surgery and pediatric traumatology. He has over 38 years of experience in the treatment of hip dysplasia, bone tumors, malformations and Perthes disease.

Experience

2013 – present | Pediatric Traumatology at the Ruber Internacional and Quirón Hospital in Pozuelo.

2004-2013|Head of the Department of Pediatric Orthopedics at the La Paz Hospital in Madrid.

1994-2004| Assistant in pediatric orthopedics at the Niño Jesus Hospital in Madrid

1992-1994 | Fellow, Department of Pediatric Orthopedics, University of Iowa (USA)

1988-1989|Research Fellow in Paediatric Orthopaedics, Oxford University (UK).

Qualification

1988 | Doctor of Medicine, Autonomous University of Madrid.

1982 | Graduated from the Faculty of Medicine of the Autonomous University of Madrid.

Education:

2004|Associate Professor of the Faculty of Medicine of the UAM.

Publications

2019|Does femoral head orientation influence acetabular development? An experimental study in Lamb. J Pediatr Orthop. 2019 Sep;39(8):416–421.

2015|Pavlik harness outcomes in Ortolani-positive hips: predictors of failure and arthrographic findings. J Child Orthop 2015 Aug;9(4):249-53.

2013|Selective triradiate epiphysiodesis for the treatment of residual experimental acetabular dysplasia. J Pediatr Orthop. 2013 Dec;33(8):821-8.

Communications and presentations

2021|Perthes Disease. Congress of Pediatric Orthopedics, SEOT, Ecuador.

2019|Dysplasia of the hip, Children's Hospital, San Jose, Costa Rica, April 2019

2018| Cerebral Palsy, ASFAPE, Madrid.

2007 | Tear and Dysplasia of the Hip, POSNA, San Diego.

2005 | Open reduction failure and DDH. Boston, IPOTT.

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

General information

Musculoskeletal radiologist, expert in sports injuries and magnetic resonance imaging with over 20 years of experience working with professional and elite athletes.

Professional experience

• Founder : Elite Sports Imaging, SL, Madrid, Spain.
• Medical consultant : Madrid Open (tennis tournament).
• Consultant : Longwood MRI Specialists, Boston, USA.
• Director of Musculoskeletal MRI and CT : Massachusetts General Hospital/Harvard Medical School (2002–2006).

Education and qualifications

• University of California, Los Angeles (UCLA) : Bachelor of Science in Kinesiology and Exercise Science (BS).
• McGill University School of Medicine : Doctor of Medicine and Master of Surgery (MD, CM).
• Boston University/Boston Medical Center : Radiology Residency.
• Harvard Medical School/Massachusetts General Hospital : Fellowship in Musculoskeletal Radiology and Interventional Radiology.
• Massachusetts Institute of Technology (MIT)/m+Visión : Postdoctoral Fellowship in Biomedical Research in Medical Imaging.

Peculiarities of professional activity

The doctor specializes in:

• Diagnosis and treatment of sports injuries using MRI and CT.
• Implementation of advanced technologies in the field of visualization of the musculoskeletal system.
• A personalized approach to diagnosing injuries in elite athletes.

The doctor has exceptional experience working at leading global institutions such as Harvard Medical School and MIT, which allows him to combine clinical practice, scientific research and the application of innovative methods in medical imaging.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

ホセ・アンヘル・オベソは、運動障害の分野で40年以上の実務経験と30年以上の研究を持つ、世界的に有名な神経学者です。博士オベソは神経変性疾患の新しい治療法を開発しています。スペイン神経学会の初の専門運動障害グループの創設者であり、運動障害、HM CINAC統合神経科学センターのディレクターを務めています。

専門分野

プロフェッサーオベソの専門知識は、神経学と神経生理学です。博士ホセ・A.・オベソは運動障害を持つ患者を治療します。医師はパーキンソン病のための継続的ドパミン刺激を開発しました。現在、博士ホセ・A.・オベソは、ドパミンニューロンを脆弱化することで、パーキンソン病の場合に機能障害を検出します。これが神経変性疾患の進行を遅らせるのに役立ちます。

職歴

• 2014年から — 主任神経学者、HM CINAC統合神経科学センターのディレクター
• 2000-2014 — 医療コンサルタント、ナバラ大学の運動障害ユニットのディレクター
• 1996-1999 — クリニカ・キロン・サン・セバスティアンおよびヴィンテルソルクリニックの神経学者
• 1986-1995 — ナバラ大学での神経学部門の責任者、運動障害ユニットおよび実験神経学研究所のディレクター
• 1982-1986 — ナバラ大学の神経学部門の副医師。

学歴

• 1976 — ナバラ大学の医学部 — 総合医学と外科の学士号
• 1979 — バスク大学の学部 — 神経学専攻
• 1979 — ナバラ大学の医学部 — 医学と外科の博士号。

研究活動

プロフェッサーオベソは350以上の研究論文を執筆しました。これらの科学的研究の大半は、ミオクローヌスおよびジストニアの治療、パーキンソン病の起源とその治療（医療および外科的）、ならびに基底核の生理病理学に捧げられています。

組織でのメンバーシップ

• アメリカ神経学会
• 国際パーキンソン病および運動障害Society。

ブランカ・ロペス・イボール・アリーニョ博士は、スペイン出身の小児血液腫瘍学の経験豊富な専門家であり、国内でトップクラスの小児神経外科医の一人でもあります。重篤な血液および癌疾患を有する子供とティーンエイジャーのケアに重点を置くHMグループの血液・小児腫瘍ユニットを率いています。ロペス・イボール博士は30年以上の実務経験を持ち、WHOおよびユネスコのコンサルタントとして働いています。教育および研究活動を提供しています。

ブランカ・ロペス・イボール博士の専門分野

医師は、特に赤血球、骨髄系、およびリンパ系の診断に関連する血液学的および癌性疾患の診断と治療を専門としています。イボール博士が治療する全ての疾患プロフィールを見るには、下にスクロールしてください。

教育

• マドリード・コンプルテンセ大学（スペイン） — 小児科および新生児ケアの医学学位
• バルセロナ大学（スペイン） — 医学のポストドクトラル学位
• メリーランド大学（アメリカ合衆国） — 小児腫瘍専門医および血液専門医。

職歴

• HM Hospitalesの血液・小児腫瘍ユニットの責任者 — 2006年から
• サン・ラファエル病院の血液・小児腫瘍部門の責任者 — 1999-2006
• ラ・サルスエラ大学病院の医師 — 1994-1999
• カタルーニャ総合大学病院の助手医師 — 1988-1993
• ニーニョ・ヘスス児童大学病院の助手医師 — 1986-1987

その他の活動

ロペス・イボール博士は2004年からスペイン保健省の小児がんの専門家として活躍しています。

ブランカ・ロペス・イボール博士は、マドリード・コンプルテンセ大学およびCEUサン・パブロ大学で講師を務めています。

医師は次を率いています：

• ハイメ・アロンソ・アブルーニャ基金 — 重篤な健康問題を抱える子供たちを支援することに重点を置いている基金。
• Curarte 基金 — 治療中の子供たちの生活の質を向上させる組織。

組織への所属

• アメリカ血液学会 (ASH)
• アメリカ小児血液腫瘍学会
• 国際小児腫瘍学会 (SIOP)
• スペイン小児科学会。

Head of the Department of Neurosurgery in the HM Hospitales Clinic

Dr. Fernando Villagrá is a respected cardiovascular surgeon who specializes in pediatric cardiac surgery. He completed his medical degree at the Complutense University of Madrid. He later earned his specialization in Cardiovascular Surgery at the Autonomous University of Madrid. His doctoral thesis received the distinction of “Outstanding Cum Laude.”

Dr. Villagrá has more than 40 years of experience. He has led pediatric cardiac surgery departments at top hospitals in Spain, including Hospital Universitario La Paz and Montepríncipe University Hospital. He has performed thousands of complex surgeries. He has also contributed to over 100 scientific publications in both international and national journals.

He is a member of the Spanish Society of Cardiology. He also serves on the editorial boards of leading medical journals. This reflects his dedication to advancing cardiovascular medicine.

名高いドクター・ロペス・イボールは、マドリード・コンプルテンセ大学で医学の学位を、バルセロナ大学で博士号を取得しています。メリーランド大学（アメリカ合衆国）で小児血液学および腫瘍学の専門家であり、骨および脳腫瘍の治療、白血病および血液疾患に精通しています。

20年以上の経験を持ち、現在はHMモンテプリンシープ病院の小児血液学および腫瘍学ユニットを指導しており、そこで子供や青年のケアが行われています。以前は、サン・ラファエル大学クリニックで同じ職務を担当していました。さらに、彼女は多くの国内および国際的な科学出版物の著者でもあります。

USP CEUでの医学、看護学、歯学における以下の科目の教育活動:

• 一般医学病理学,

• 口腔・顎顔面腫瘍学,

• 一般およびプロペデューティック病理学,

• 医学病理学 I,

• 医学病理学 II,

• 医学病理学 III,

• 緩和ケアにおける看護学,

• 生命倫理学,

• 病態生理学,

• セミオロジー,

• 消化器系の病理学,

• 腫瘍学

• CIOCCの実習における医学部学生の指導教員。

• HM CIOCCの腫瘍科ユニットでの外部ローテーション生の指導教員: (2009-2016年)

• 細胞性腫瘍形成に関する修士課程の准教授。

• HM CIOCC USP CEU における腫瘍学の臨床および応用研究における修士研究の博士課程管理者。

• USP CEUおよびHM Hospitalesの大学院修士実習の責任指導者。

• MDアンダーソンがんセンター 栄養およびがん進歩コース。

• 消化器新生物に関するI-IX国際コース。HM CIOCC。

• 2014/2015学年度の学生、研修医、およびローテーションスタッフに対するチュートリアル会議。

• 医療腫瘍サービスプログラムの指導教員。